{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T17:40:10Z","timestamp":1748540410779,"version":"3.41.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:p>A 46-year-old Asian female patient with thyroid eye disease reported ocular irritation, eyelid swelling, diplopia, and pain with eye movement. The patient was diagnosed with active thyroid eye disease and secondary thyroid eye disease\u2013acquired epiblepharon, which was causing bilateral punctate epithelial erosion. Treatment was started with newly U.S. Food and Drug Administration approved teprotumumab, an insulin-like growth factor-1 receptor inhibitor. Four infusion treatments later, the patient\u2019s epiblepharon was alleviated with minimal side effects. In this report, the authors present a case of thyroid eye disease\u2013acquired epiblepharon resolving with teprotumumab treatment.<\/jats:p>","DOI":"10.1097\/iop.0000000000002002","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T14:08:19Z","timestamp":1626444499000},"page":"e195-e196","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Acquired Epiblepharon Alleviated With Teprotumumab Treatment in Active Thyroid Eye Disease Patient"],"prefix":"10.1097","volume":"37","author":[{"given":"Kevin W.","family":"Chen","sequence":"first","affiliation":[{"name":"Drexel University College of Medicine, Philadelphia, Pennsylvania, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul O.","family":"Phelps","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology, Department of Surgery, NorthShore University HealthSystem, Evanston, Illinois, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"key":"R1-20250529","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.IOP.0000160597.59156.79","article-title":"Acquired lower epiblepharon in patients with thyroid eye disease.","volume":"21","author":"Chang","year":"2005","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R2-20250529","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.disamonth.2014.03.010","article-title":"Thyroid eye disease for the primary care physician.","volume":"60","author":"Phelps","year":"2014","journal-title":"Dis Mon"},{"key":"R3-20250529","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.4049\/jimmunol.181.6.4397","article-title":"Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves\u2019 disease.","volume":"181","author":"Tsui","year":"2008","journal-title":"J Immunol"},{"key":"R4-20250529","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for thyroid-associated ophthalmopathy.","volume":"376","author":"Smith","year":"2017","journal-title":"N Engl J Med"},{"key":"R5-20250529","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/01.APO.0000617916.50176.b2","article-title":"Thyroid eye disease-related epiblepharon: a comparative case study.","volume":"9","author":"Zhao","year":"2020","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"R6-20250529","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3341\/kjo.2012.26.5.319","article-title":"Outcomes of various surgical procedures on acquired lower eyelid epiblepharon in thyroid associated ophthalmopathy.","volume":"26","author":"Park","year":"2012","journal-title":"Korean J Ophthalmol"},{"key":"R7-20250529","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/bjophthalmol-2014-305649","article-title":"Thyroid eye disease: a Southeast Asian experience.","volume":"99","author":"Lim","year":"2015","journal-title":"Br J Ophthalmol"},{"author":"Jain","journal-title":"Br J Ophthalmol","article-title":"Teprotumumab reduces extraocular muscle and orbital fat volume in thyroid eye disease [published online ahead of print 2020 November 10, 2020].","key":"R8-20250529"},{"key":"R9-20250529","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1136\/bjo.84.12.1407","article-title":"Surgical correction for lower lid epiblepharon in Asians.","volume":"84","author":"Woo","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"R10-20250529","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ophtha.2011.07.048","article-title":"Acquired lower eyelid epiblepharon in thyroid-associated ophthalmopathy of Koreans.","volume":"119","author":"Park","year":"2012","journal-title":"Ophthalmology"},{"key":"R11-20250529","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00002341-199807000-00001","article-title":"The Asian lower eyelid: a comparative anatomic study using high-resolution magnetic resonance imaging.","volume":"14","author":"Carter","year":"1998","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R12-20250529","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/jamaophthalmol.2020.5296","article-title":"Teprotumumab for optic neuropathy in thyroid eye disease.","volume":"139","author":"Slentz","year":"2021","journal-title":"JAMA Ophthalmol"}],"container-title":["Ophthalmic Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IOP.0000000000002002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T17:05:34Z","timestamp":1748538334000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IOP.0000000000002002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/iop.0000000000002002","relation":{},"ISSN":["0740-9303"],"issn-type":[{"type":"print","value":"0740-9303"}],"subject":[],"published":{"date-parts":[[2021,7,15]]}}}